Group 1 - The Hong Kong Innovative Drug ETF (159567) experienced a decline of 1.32% on August 1, with a trading volume of 3.137 billion yuan [1] - The fund's shares decreased by 20 million, bringing the total shares to 2.447 billion, with an increase of 450 million shares over the past 20 trading days [1] - The latest net asset value of the fund is 4.532 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the National Index of Hong Kong Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Yinhua Fund Management Co., Ltd., with Ma Jun as the fund manager [1] - Since its inception on January 3, 2024, the fund has achieved a return of 85.16%, with a return of 22.72% over the past month [1]
8月1日港股创新药ETF（159567）份额减少2000.00万份，最新份额24.47亿份，最新规模45.32亿元
Xin Lang Cai Jing·2025-08-04 01:12